Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity

Molecular and Cellular Neuroscience

Volumn 39, Issue 2, 2008, Pages 285-290

  Trzaska, Katarzyna A ^a   Reddy, Bobby Y ^a   Munoz, Jessian L ^b   Li, Ke Yong ^a   Ye, Jiang Hong ^a   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PUERTO RICO AT CAYEY   (Puerto Rico)

Author keywords

Dopamine; Mesenchymal stem cells; Neural repair; REST NRSF

Indexed keywords

DOPAMINE; FIBROBLAST GROWTH FACTOR; RE 1 SILENCING TRANSCRIPTION FACTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ARTICLE; CELL MATURATION; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; MATURITY; MESENCHYMAL STEM CELL; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOPHYSICAL PROCESSES; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOPAMINE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE POTENTIALS; MESENCHYMAL STEM CELLS; NERVE TISSUE PROTEINS; NEURONS; PATCH-CLAMP TECHNIQUES; PHOSPHOPYRUVATE HYDRATASE; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; SODIUM CHANNELS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

ERINACEIDAE;

EID: 52049101771     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.07.006     Document Type: Article

References (27)

1. Alhadlaq A., and Mao J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 13 (2004) 436-448
2. Ballas N., Grunseich C., Lu D.D., Speh J.C., and Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121 (2005) 645-657
3. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
4. Caplan A.I., and Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7 (2001) 259-264
5. Cho K.J., Trzaska K.A., Greco S.J., McArdle J., Wang F.S., Ye J.H., and Rameshwar P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23 (2005) 383-391
6. Chong J.A., Tapia-Ramirez J., Kim S., Toledo-Aral J.J., Zheng Y., Boutros M.C., Altshuller Y.M., Frohman M.A., Kraner S.D., and Mandel G. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80 (1995) 949-957
7. Coulson J.M. Transcriptional regulation: cancer, neurons and the REST. Curr. Biol. 15 (2005) R665-R668
8. Dezawa M., Kanno H., Hoshino M., Cho H., Matsumoto N., Itokazu Y., Tajima N., Yamada H., Sawada H., Ishikawa H., Mimura T., Kitada M., Suzuki Y., and Ide C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113 (2004) 1701-1710
9. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., and Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (2001) 710-719
10. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., and Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro - potential therapeutic application for Parkinsonism. Stem Cells 14 (2006) 115-124
11. Greco S.J., and Rameshwar P. Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J. Immunol. 179 (2007) 3342-3350
12. Greco S.J., Smirnov S.V., Murthy R.G., and Rameshwar P. Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J. Biol. Chem. 282 (2007) 30039-30050
13. Greco S.J., Zhou C., Ye J.H., and Rameshwar P. An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev. 16 (2007) 811-826
14. Kim S.M., Yang J.W., Park M.J., Lee J.K., Kim S.U., Lee Y.S., and Lee M.A. Regulation of human tyrosine hydroxylase gene by neuron-restrictive silencer factor. Biochem. Biophys. Res. Commun. 346 (2006) 426-435
15. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332 (1995) 1118-1124
16. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 Suppl (2004) S42-S50
17. Majumder S. REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 5 (2006) 1929-1935
18. Patel S.A., Sherman L., Munoz J., and Rameshwar P. Immunological properties of mesenchymal stem cells and clinical implications. Arch. Immunol. Ther. Exp. (Warsz). 56 (2008) 1-8
19. Potian J.A., Aviv H., Ponzio N.M., Harrison J.S., and Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171 (2003) 3426-3434
20. Sun Y.M., Greenway D.J., Johnson R., Street M., Belyaev N.D., Deuchars J., Bee T., Wilde S., and Buckley N.J. Distinct profiles of REST interactions with its target genes at different stages of neuronal development. Mol. Biol. Cell 16 (2005) 5630-5638
21. Suon S., Yang M., and Iacovitti L. Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res. 1106 (2006) 46-51
22. Tapia-Ramirez J., Eggen B.J., Peral-Rubio M.J., Toledo-Aral J.J., and Mandel G. A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1177-1182
23. Trzaska K.A., Kuzhikandathil E.V., and Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25 (2007) 2797-2808
24. Wood I.C., Belyaev N.D., Bruce A.W., Jones C., Mistry M., Roopra A., and Buckley N.J. Interaction of the repressor element 1-silencing transcription factor (REST) with target genes. J. Mol. Biol. 334 (2003) 863-874
25. Xiao C., Zhang J., Krnjevic K., and Ye J.H. Effects of ethanol on midbrain neurons: role of opioid receptors. Alcohol Clin. Exp. Res. 31 (2007) 1106-1113
26. Xiao C., Zhou C., Li K., and Ye J.H. Presynaptic GABAA receptors facilitate GABAergic transmission to dopaminergic neurons in the ventral tegmental area of young rats. J. Physiol. 580 (2007) 731-743
27. Zipori D. Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol. Dis. 33 (2004) 211-215